Anixa Biosciences Inc financial data

Symbol
ANIX on Nasdaq
Location
San Jose, CA
Fiscal year end
31 October
Latest financial report
10-Q - Q2 2025 - 10 Sep 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 879% % -34%
Debt-to-equity 13% % 56%
Return On Equity -67% % -23%
Return On Assets -59% % -17%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32,916,915 shares 2.3%
Common Stock, Shares, Outstanding 32,822,109 shares 2.1%
Entity Public Float $90,560,860 USD -25%
Common Stock, Value, Issued $328,000 USD 2.2%
Weighted Average Number of Shares Outstanding, Basic 32,476,000 shares 1.3%
Weighted Average Number of Shares Outstanding, Diluted 32,476,000 shares 1.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $5,405,000 USD -17%
General and Administrative Expense $6,583,000 USD -8.4%
Costs and Expenses $11,988,000 USD -13%
Operating Income (Loss) $11,988,000 USD 13%
Net Income (Loss) Attributable to Parent $11,115,000 USD 10%
Earnings Per Share, Basic 0 USD/shares 36%
Earnings Per Share, Diluted 0 USD/shares 36%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,495,000 USD 22%
Cash, Cash Equivalents, and Short-term Investments $20,745,000 USD
Assets, Current $17,449,000 USD -23%
Operating Lease, Right-of-Use Asset $202,000 USD -15%
Assets $17,651,000 USD -23%
Accounts Payable, Current $276,000 USD -8.6%
Accrued Liabilities, Current $1,751,000 USD 4.4%
Liabilities, Current $2,066,000 USD 3.1%
Operating Lease, Liability, Noncurrent $174,000 USD -18%
Liabilities $2,240,000 USD 1%
Retained Earnings (Accumulated Deficit) $248,982,000 USD -4.7%
Stockholders' Equity Attributable to Parent $16,595,000 USD -24%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $15,411,000 USD -26%
Liabilities and Equity $17,651,000 USD -23%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,904,000 USD -26%
Net Cash Provided by (Used in) Financing Activities $17,000 USD -101%
Net Cash Provided by (Used in) Investing Activities $2,703,000 USD 1995%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 32,822,109 shares 2.1%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $218,000 USD -363%
Operating Lease, Liability $213,000 USD -10%
Lessee, Operating Lease, Liability, to be Paid $271,000 USD -16%
Operating Lease, Liability, Current $39,000 USD 62%
Lessee, Operating Lease, Liability, to be Paid, Year Two $64,000 USD 1.6%
Lessee, Operating Lease, Liability, to be Paid, Year One $63,000 USD 12%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $58,000 USD -33%
Lessee, Operating Lease, Liability, to be Paid, Year Three $66,000 USD 1.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 19,860 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $63,000 USD -4.5%
Additional Paid in Capital $265,249,000 USD 2.3%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 100 USD/shares 0%